Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study MP Bogenschutz, AA Forcehimes, JA Pommy, CE Wilcox, PCR Barbosa, ... Journal of psychopharmacology 29 (3), 289-299, 2015 | 999 | 2015 |
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum CM Wilson, AE Serrano, A Wasley, MP Bogenschutz, AH Shankar, ... Science 244 (4909), 1184-1186, 1989 | 585 | 1989 |
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ... Focus 21 (3), 315-328, 2023 | 420 | 2023 |
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial GE Woody, SA Poole, G Subramaniam, K Dugosh, M Bogenschutz, ... Jama 300 (17), 2003-2011, 2008 | 394 | 2008 |
Sacred knowledge: Psychedelics and religious experiences WA Richards Columbia University Press, 2015 | 251 | 2015 |
Classic hallucinogens in the treatment of addictions MP Bogenschutz, MW Johnson Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, 250-258, 2016 | 250 | 2016 |
Olanzapine versus placebo in the treatment of borderline personality disorder MP Bogenschutz, HG Nurnberg Journal of Clinical Psychiatry 65 (1), 104-109, 2004 | 233 | 2004 |
Development of a bibliography on religion, spirituality and addictions C Geppert, MP Bogenschutz, WR Miller Drug and alcohol review 26 (4), 389-395, 2007 | 197 | 2007 |
Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance RJ Thoma, MA Monnig, PA Lysne, DA Ruhl, JA Pommy, M Bogenschutz, ... Alcoholism: Clinical and Experimental Research 35 (1), 39-46, 2011 | 180 | 2011 |
Cognitive control in alcohol use disorder: deficits and clinical relevance CE Wilcox, CJ Dekonenko, AR Mayer, MP Bogenschutz, JA Turner Reviews in the Neurosciences 25 (1), 1-24, 2014 | 161 | 2014 |
Health status of ayahuasca users PCR Barbosa, S Mizumoto, MP Bogenschutz, RJ Strassman Drug testing and analysis 4 (7-8), 601-609, 2012 | 144 | 2012 |
Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial MP Bogenschutz, S Ross, S Bhatt, T Baron, AA Forcehimes, E Laska, ... JAMA psychiatry 79 (10), 953-962, 2022 | 129 | 2022 |
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial MP Bogenschutz, DM Donovan, RN Mandler, HI Perl, AA Forcehimes, ... JAMA internal medicine 174 (11), 1736-1745, 2014 | 123 | 2014 |
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses MP Bogenschutz, JM Pommy Drug testing and analysis 4 (7-8), 543-555, 2012 | 114 | 2012 |
Pharmacotherapy for pregnant women with addictions WF Rayburn, MP Bogenschutz American Journal of Obstetrics and Gynecology 191 (6), 1885-1897, 2004 | 103 | 2004 |
Therapeutic applications of classic hallucinogens MP Bogenschutz, S Ross Behavioral neurobiology of psychedelic drugs, 361-391, 2018 | 98 | 2018 |
Psychological and neuropsychological assessment of regular hoasca users PCR Barbosa, RJ Strassman, DX Da Silveira, K Areco, R Hoy, J Pommy, ... Comprehensive psychiatry 71, 95-105, 2016 | 98 | 2016 |
Examining an affect regulation model of substance abuse in schizophrenia: the role of traits and coping JJ Blanchard, D Squires, T Henry, WP Horan, M Bogenschutz, J Lauriello, ... The Journal of nervous and mental disease 187 (2), 72-79, 1999 | 94 | 1999 |
Spirituality and addiction WR Miller, MP Bogenschutz Southern Medical Journal 100 (4), 433-437, 2007 | 93 | 2007 |
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder MP Bogenschutz, SK Podrebarac, JH Duane, SS Amegadzie, TC Malone, ... Frontiers in pharmacology 9, 100, 2018 | 90 | 2018 |